Prolonged release of drug from O/w emulsion and residence in rat nasal cavity

Pharmaceutical Development and Technology

Volumn 3, Issue 4, 1998, Pages 461-469

  Aikawa, Katsuyoshi ^a   Matsumoto, Keiko ^a   Uda, Harumi ^a   Tanaka, Shigeo ^a   Shimamura, Haruo ^a   Aramaki, Yukihiko ^b   Tsuchiya, Seishi ^b  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Chlorpheniramine maleate; Deposit method; Dialysis tube method; Drug disappearance; Medium chain triglycerides (MCT); O w emulsion

Indexed keywords

CHLORPHENIRAMINE MALEATE; MEDIUM CHAIN TRIACYLGLYCEROL;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; NONHUMAN; NOSE CAVITY; PH; PRIORITY JOURNAL; RAT;

EID: 0031739220     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459809028627     Document Type: Article

References (32)

1. M. Okuda, Mechanisms in Nasal Allergy, Allergy-Immunologic and Management Considerations (T. Spencer, ed.), MEDED, FL, 1982.
2. N. Cuana, Blood and nerve supply of the nasal lining, in The Nose: Upper Airway Physiology and the Atmosphere Environment (D. F. Proctor and I. Anderson, eds.), Elsevier, Amsterdam, 1982, pp. 45-66.
3. K. Morimoto, H. Tabata, and K. Morisaka, Nasal absorption of nifedipine from gel preparations in rats. Chem. Pharm. Bull, 35, 3041-3044 (1987).
4. K. Morimoto, K. Morisaka, and A. Kamada, Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel, J. Pharm. Pharmacol., 37, 134-136 (1985).
5. A. S. Harris, E. Svensson, Z. G. Wagner, S. Lethagen, and I. M. Nilsson, Effect of viscosity on particle size, deposition, and clearance of nasal delivery systems containing desmopressin. J. Pharm. Sci., 77, 405-408 (1988).
6. A. K. Pennington, J. H. Ratcliffe, C. G. Wilson, and J. G. Hardy, The influence of solution viscosity on nasal spray deposition and clearance, Int. J. Pharm., 43, 221-224 (1988).
7. J. G. Wagner, E. S. Gerard, and D. G. Kaiser, The effect of the dosage form on serum levels of indoxole, Clin. Pharmacol. Ther., 7, 610-619 (1966).
8. K. Kakemi, H. Sezaki, S. Muranishi, H. Ogata, and S. Isemura, Mechanism of intestinal absorption of drugs from oil in water emulsions I, Chem. Pharm. Bull., 20, 708-714 (1972).
9. K. Kakemi, H. Sezaki, S. Muranishi, H. Ogata, and K. Giga, Mechanism of intestinal absorption of drugs from oil in water emulsions II. Absorption from oily solutions, Chem. Pharm. Bull., 20, 715-720 (1972).
10. T. Kimura, K. Takeda, A. Kageyu, M. Toda, Y. Kurosaki, and T. Nakayama, Intestinal absorption of dolichol from emulsions and liposomes in rats, Chem. Pharm. Bull., 37, 463-466 (1989).
11. H. Toguchi, Y. Ogawa, and T. Shimamoto, Effects of the physicochemical properties of the emulsion formulation on the bioavailability of ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropyloxy)phenyl)propionate in rats, Chem. Pharm. Bull., 38, 2797-2800 (1990).
12. A. Rubinstein, Y. V. Pathak, J. Kleinstern, A. Reches, and S. Benita, In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsions, J. Pharm. Sci., 80, 643-647 (1991).
13. H. Sasaki, Y. Takakura, M. Hashida, T. Kimura, and H. Sezaki, Antitumour activity of lipophilic prodrugs of mitomycin C entrapped in liposome or o/w emulsions, J. Pharm. Dyn., 7, 120-130 (1984).
14. S. Benita, D. Friedman, and M. Weinstock, Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits, J. Pharm. Pharmacol., 38, 653-658 (1986).
15. D. Friedman and S. Benita, A mathematical model for drug release from o/w emulsions: application to controlled release morphine emulsions, Drug Dev. Ind. Pharm., 13, 2067-2085 (1987).
16. Y. Nakamoto, M. Hashida, S. Muranishi, and H. Sezaki, Studies on pharmaceutical modification of anticancer agents. II. Enhanced delivery of bleomycin into lymph by emulsions and drying emulsions, Chem. Pharm. Bull., 23, 3125-3131 (1975).
17. R. A. Myers and V. J. Stella, Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats, Int. J. Pharm., 78, 217-226 (1992).
18. T. T. Kararli, T. E. Needham, G. Schoenhard, D. A. Baron, R. E. Schmidt, B. Katz, and B. Belonio, Enhancement of nasal delivery of a renin inhibitor in the rat using emulsion formulations, Pharm. Res., 9, 1024-1028 (1992).
19. N. Aoyagi, N. Kaniwa, Y. Takeda, M. Uchiyama, F. Takamura, and Y. Kido, Release rates of indomethacin from commercial witepsol suppositories and the bioavailabilities in rabbits and pigs, Chem. Pharm. Bull., 36, 4933-4940 (1988).
20. S. Hirai, T. Yashiki, and H. Mima, Absorption of drugs from the nasal mucosa of the rat, Int. J. Pharm., 7, 317-325 (1981).
21. K. Aikawa, M. Takahashi, H. Uda, S. Tanaka, T. Yoshida, and S. Tsuchiya, Effect of pharmaceutical properties on disappearance rate of chlorpheniramine maleate from nasal cavity in rat in situ nasal deposit method, Yakuzaigaku, 51, 205-211 (1991).
22. S. M. Wallance and G. Barnett, Pharmacokinetic analysis of percutaneous absorption: evidence of parallel penetration pathways for methotrexate, Pharmacokinet. Biopharm., 6, 315-325 (1978).
23. W. Bialik, Studies on the release of drugs from o/w emulsion ointments using the mathematical interpretations. Part 2: Influence of the ointment composition, Pharmazie, 40, 637-639 (1985).
24. A. H. Goldberg, W. I. Higuchi, N. F. H. Ho, and G. Zografi, Mechanisms of interphase transport I. Theoretical considerations of diffusion and interfacial barriers in transport of solubilized systems, J. Pharm. Sci., 56, 1432-1437 (1967).
25. R. T. Lostrito, L. Goei, and S. L. Silvestri, Theoretical considerations of drug release from submicron oil in water emulsions, J. Parent. Sci. Technol., 41, 215-219 (1987).
26. T. Yotsuyanagi, W. I. Higuchi, and A. H. Ghanem, Theoretical treatment of diffusional transport into and through an oil-water emulsion with an interfacial barrier at the oil-water interface, J. Pharm. Sci., 62, 40-43 (1973).
27. W. Bialik, Studies on the release of drugs from o/w emulsion ointments using the mathematical interpretations. Part 3: Kinetic approach, Pharmazie 42, 317-320 (1987).
28. M. Y. Levy and S. Benita, Drug release from submicron o/w emulsion: A new in vitro kinetic evaluation model, Int. J. Pharm., 66, 29-37 (1990).
29. N. Ammoury, H. Fessi, J. P. Devissaguet, F. Puisieux, and S. Benita, In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules, J. Pharm. Sci., 79, 763-767 (1990).
30. N. S. S. Magalhaes, G. Cave, M. Seiller, and S. Benita, The stability and in vitro release kinetics of a clofibride emulsion, Int. J. Pharm., 76, 225-237 (1991).
31. N. J. Greenberger, J. B. Rodgers, and K. J. Isselbacher, Factors influencing their hydrolysis and transport, J. Clin. Invest., 45, 217-227 (1966).
32. K. Higaki, I. Kishimoto, H. Komatsu, M. Hashida, and H. Sezaki, Effect of medium-chain glycerides on the intestinal absorption and the hepatobiliary transport of phenol red, Int. J. Pharm., 36, 131-139 (1987).